Combination of psychedelic, CBT shows promise in AUD treatment
Alcoholism & Drug Abuse Weekly August 24, 2026 DOI: 10.1002/adaw.35025 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Qualitative study Peer reviewed |
|---|---|
| Sample size | 10 |
| Population | Participants in a Phase 2a trial of a psychedelic combined with CBT for alcohol use disorder |
| Intervention | Psychedelic |
| Duration | 12-week follow-up |
| Key findings | Most interviewed participants (8 of 10) reported eliminating or reducing drinking over a 12-week follow-up, describing the experience as transformative, though several found it challenging. |
Abstract
Participants in a Phase 2a trial of a single‐dose psychedelic in combination with cognitive‐behavioral therapy (CBT) for alcohol use disorder (AUD) used terms such as “cleansing” and “rebirth” to describe the impact of their study experience. All but two of the study's 10 interviewed participants reported eliminating or reducing drinking over a 12‐week follow‐up, though several described their overall experience as challenging.